Atherosclerosis of the intracranial arteries – current view, 2^nd part

Czech version

Authors: J. Žižka
Authors‘ workplace: I. interní klinika, FTNsP/IPVZ, Praha ⁴⁴
Published in: Kardiol Rev Int Med 2012, 14(1): 40-45

Overview

Atherosclerosis of the intracranial arteries – current view, 2^nd part. Atherosclerosis of the intracranial arteries is a relatively frequent illness and symptomatic impairment of the intracranial arterial bed represents a serious prognosis. This prognosis is unfavourable chiefly in patients with heavy, i.e. more than 70%, stenoses. Currently, the development of non-invasive and minimally invasive diagnostic methods has meant a significant rise in the amount of available information about this illness. Nevertheless, options for treatment remain limited and do not bring satisfactory results. The treatment given to the majority of patients is conservative, with a focus on antithrombotic treatment and an aggressive attempt to influence the risk factors in atherosclerosis. Based on recently published data, this should continue to be the case. The report is divided into two parts, the second of which is devoted to diagnostics and treatment.

Keywords:
atherosclerosis – intracranial stenoses – diagnosis – transcranial duplex sonography – antithrombotic treatment – endovascular intervention

Sources

1. Nguyen-Huynh MN, Wintermark M, English J et al. How Accurate is CT Angiogramy in Evaluating Intracranial Atherosclerotic Disease? Stroke 2008; 39: 1184–1188.

2. Bash S, Villablanca JP, Jahan R et al. Intracranial vascular stenosis and occlusive disease. Evaluation with CT angiogramy, MR angiogramy, and digital subtraction angiogramy. AJNR Am J Neuroradiol 2005; 26: 1012–1021.

3. Wong KS, Liang EY, Lam WW et al. Spiral computed tomography angiogramy in the assessment of middle cerebral artery occlusive dinase. J Neurol Nerosurg Psychiatry 1995; 59: 537–539.

4. Feldmann E, Wilterdink JL, Kosinski A et al. Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) Trial Investigators. The Stroke outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 2007; 68: 2099–2106.

5. Bash S, Villablanca JP, Jahan R et al. Intracranial vascular stenosis and occlusive disease. Evaluation with CT angiogramy, MR angiogramy, and digital subtraction angiogramy. AJNR Am J Neuroradiol 2005; 26: 1012–1021.

6. Školoudík D, Majvald Č, Chudoba V et al. Možnosti neinvazivní diagnostiky intrakraniálních stenóz pomocí transkraniální duplexní sonografie a MR angiografie. Čes Radiol 1999; 53 (Suppl 1): 42–46.

7. Žižka J. Transkraniální barevná duplexní sonografie v hodnocení intrakraniálních tepen při cerebrovaskulárním stenookluzivním onemocnění – přehled. Kardiol Rev 2010; 12: 88–93.

8. Arenillas JF. Intracranial Atherosclerosis. Current Concepts. Stroke 2011; 42 (Suppl 1): S20–S23.

9. Kasner SE, Lynn MJ, Chimowitz MI et al. Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Warfarin vs aspirin for symptomatic intracranial stenosis: Subgroup analyses from WASID. Neurology 2006; 67: 1275–1278.

10. Turan TN, Maidan L, Cotsonis G et al. Warfarin-Aspirin Symptomatic Intracranial Disease Investigators. Failure of Antithrombotic Therapy and Risk of Stroke in Patiens With Symptomatic Intracranial Stenosis. Stroke 2009; 40: 505–509.

11. Wong KSL, Chen C, Fu J et al. CLAIR study investigators. Clopidogrel plus aspirin alone for reducing embolisation in patiens with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010; 9: 489–497.

12. Markus HS, Droste DW, Kaps M et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial. Circulation 2005; 111: 2233–2240.

13. Diener HC, Bogousslavsky J, Brass LM et al. MATCH investigators. Aspirin and clopidogrel compared with clopidogrela alone after recent ischaemic stroke or transient ischaemic attack in high-risk patiens (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 331–337.

14. Kwon S, Cho YJ, Koo JS et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial stenosis. Stroke 2005; 36: 782–786.

15. Kalita Z, Keller O, Bar M a spol. Doporučený postup sekundární prevence recidivy po akutní cévní mozkové příhodě [(iCMP) – mozkovém infarktu/tranzitorní ischemické atace (TIA) a hemoragické CMP] http://www.cmp.cz/jnp/cz/doporucene_postupy_pro_lecbu_cmp/cv_sekce_cns-sekundarni_prevence_po_cmp.html, 11.8.2011.

16. Brott TG, Halperin JL, Abbara S et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery Developed in Collaboration With the American Academy of Neurology and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2011; 57: e16–94.

17. Chaturvedi S, Turan TN, Lynn MJ et al. WASID Study Group. Risk factor status and vascular events in patiens with symptomatic intracranial stenosis. Neurology 2007; 69: 2063–2068.

18. Turan TN, Cotsonis G, Lynn MJ et al. Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Relationship between blood pressure and stroke recurrence in patiens with intracranial arterial stenosis. Circulation 2007; 115: 2969–2975.

19. Turan TN, Derdeyn CP, Fiorella D et al. Treatment of atherosclerotic intracranial arterial stenosis. Stroke 2009; 40: 2257–2261.

20. Mancia G, Laurent S, Agabiti-Rosei E et al. European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121–2158.

21. Turan TN, Derdeyn CP, Fiorella D et al. Treatment of atherosclerotic intracranial arterial stenosis. Stroke 2009; 40: 2257–2261.

22. Quershi AI, Hussein HM, El-Gengaihy A et al. Concurrent comparison of outcomes of primary angioplasty and of stent placement in high-risk patiens with symptomatic intracranial stenosis. Neurosurgery 2008; 62:1053–1062.

23. Mazighi M, Yadav JS, Abou-Chebl A. Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke 2008; 39: 1766–1769.

24. Siddiq F, Vazquez G, Momon MZ et al. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic disease: a multicenter study. Stroke 2008; 39: 2505–2510.

25. Meyers PM, Schumacher HC, Higashida RT et al. American Heart Association. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009; 119: 2235–2249.

26. Schumacher HC, Meyers MP, Higashida RT et al. Reporting Standards for Angioplasty and Stent-Assisted Angioplasty for Intracranial Atherosclerosis. Stroke 2009; 40: e348–e365.

27. Chimowitz MI, Lynn MJ, Derdeyn CP et al. Stenting versus Medical Therapy for Intracranial Arterial Stenosisi. N Engl J Med 2011; 365: 993–1003.

28. Zaidat OO, Klucznik R, Alexander MJ et al. The NIH registry on use of the Wingspan stent for symptomatic 7%–90% intracranial arterial stenosis. Neurology 2008; 70: 1518–1524.